Maduell Francisco, Navarro Victor, Torregrosa Eduardo, Rius Asunción, Dicenta Fernando, Cruz Maria Carmen, Ferrero J Antonio
Department of Nephrology, Hospital General de Castellón, Spain.
Kidney Int. 2003 Jul;64(1):305-13. doi: 10.1046/j.1523-1755.2003.00043.x.
Daily dialysis has shown excellent clinical results because a higher frequency of dialysis is more physiologic. On-line hemodiafiltration (OL-HDF) is a HDF technique that combines diffusion with high convection in which the dialysis fluid itself is used as a reinfusion solution. The aim of this study was to demonstrate the beneficial effect of the more effective dialysis schedule (daily dialysis) with the dialysis modality that offers the highest uremic toxin removal (on-line HDF).
Eight patients, six males and two females, on standard 4 to 5 hours three times a week OL-HDF (S-OL-HDF) were switched to daily OL-HDF (D-OL-HDF) 2 to 21/2 hours six times per week. Dialysis parameters were identical during both periods and only frequency and dialysis time of each session were changed. Tolerance, uremic toxin removal, urea kinetics, biochemical and anemia profiles, blood pressure, and left ventricular hypertrophy were evaluated.
D-OL-HDF was well accepted and tolerated. The disappearance of postdialysis fatigue was rapidly reported by patients. Patients mantained the same [time average concentration (TAC) and weekly single-pool Kt/V (spKt/V)] throughout the study. However, equivalent renal urea clearance (EKR), standard Kt/V and weekly urea reduction ratio (URR) were increased during D-OL-HDF. Weekly urea, creatinine, osteocalcin, beta2-microglobulin, myoglobin, and prolactin reduction ratios were improved with D-OL-HDF. There was a significant decrease in predialysis plasma levels of urea, creatinine, acid uric, beta2-microglobulin and homocysteine over 6 months. Phosphate binders were reduced and antihypertensive drugs were stopped. A 30% regression of left ventricular mass was observed.
The change from S-OL-HDF to D-OL-HDF was well tolerated. Disappearance of postdialysis fatigue, better dialysis adequacy, a higher removal of middle and large molecules, a reduction of phosphate binders, improvement of status nutritional, and an important reduction of cardiovascular risk factors were observed.
每日透析已显示出优异的临床效果,因为更高频率的透析更符合生理需求。在线血液透析滤过(OL-HDF)是一种将弥散与高流量对流相结合的血液透析滤过技术,其中透析液本身用作再输注溶液。本研究的目的是证明采用能实现最高尿毒症毒素清除率的透析方式(在线HDF)的更有效透析方案(每日透析)的有益效果。
8例患者,6例男性和2例女性,从标准的每周3次、每次4至5小时的OL-HDF(S-OL-HDF)转换为每周6次、每次2至2.5小时的每日OL-HDF(D-OL-HDF)。两个阶段的透析参数相同,仅每次透析的频率和时间发生了变化。评估了耐受性、尿毒症毒素清除情况、尿素动力学、生化和贫血指标、血压以及左心室肥厚情况。
D-OL-HDF被很好地接受和耐受。患者很快报告透析后疲劳消失。在整个研究过程中,患者的[时间平均浓度(TAC)和每周单池Kt/V(spKt/V)]保持不变。然而,在D-OL-HDF期间,等效肾尿素清除率(EKR)、标准Kt/V和每周尿素清除率(URR)有所增加。D-OL-HDF使每周尿素、肌酐、骨钙素、β2-微球蛋白、肌红蛋白和催乳素的清除率得到改善。6个月内透析前血浆尿素、肌酐尿酸、β2-微球蛋白和同型半胱氨酸水平显著下降。磷酸盐结合剂用量减少,降压药物停用。观察到左心室质量减轻30%。
从S-OL-HDF转换为D-OL-HDF耐受性良好。观察到透析后疲劳消失、透析充分性更好、中大分子清除率更高、磷酸盐结合剂用量减少、营养状况改善以及心血管危险因素显著降低。